BIOMAT Database Logo BIOMAT Database Logo

Sublingual captopril versus nifedipine in hypertensive crises. 1985

L H Opie, and A Jennings

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D009060 Mouth Floor The area of the mouth beneath the TONGUE. Floor of Mouth,Sublingual Region,Floor, Mouth,Floors, Mouth,Mouth Floors,Region, Sublingual,Regions, Sublingual,Sublingual Regions
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D011392 Proline A non-essential amino acid that is synthesized from GLUTAMIC ACID. It is an essential component of COLLAGEN and is important for proper functioning of joints and tendons. L-Proline,L Proline
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

L H Opie, and A Jennings
Comparison of sublingual captopril and nifedipine in hypertensive crises.
January 1987, Archives of internal medicine,
L H Opie, and A Jennings
[Sublingual captopril in hypertensive crises].
September 1992, Recenti progressi in medicina,
L H Opie, and A Jennings
[Sublingual captopril in hypertensive crises].
February 1988, Medicina clinica,
L H Opie, and A Jennings
[Sublingual nifedipine in hypertensive crises].
January 1981, Bollettino della Societa italiana di cardiologia,
L H Opie, and A Jennings
[Sublingual captopril versus nifedipine in the treatment of hypertensive crisis].
April 1991, Revista medica de Chile,
L H Opie, and A Jennings
[Sublingual captopril in the treatment of hypertensive crises].
April 1986, Medicina clinica,
L H Opie, and A Jennings
[The use of sublingual captopril in hypertensive crises].
September 1994, Investigacion clinica,
L H Opie, and A Jennings
[Hypertensive crisis: comparative study of oral captopril, sublingual captopril and sublingual nifedipine].
June 1987, Medicina clinica,
L H Opie, and A Jennings
Comparison of sublingual captopril and sublingual nifedipine in hypertensive emergencies.
February 1990, Japanese journal of pharmacology,
L H Opie, and A Jennings
Dose-response effect of sublingual captopril in hypertensive crises.
July 1988, Journal of clinical pharmacology,
Copied contents to your clipboard!